Navigation Links
Herceptin and chemo improves response rates without major adverse effects in HER2 breast cancer
Date:4/18/2008

itabine (DX), or a combination of both D and DX, or four cycles of D followed by four cycles of DX. Women with HER2-positive tumours also received trastuzumab at the same time as the neoadjuvant chemotherapy, and then continued with it after surgery for up to one year. Both the chemotherapy and the trastuzumab were given via three-weekly infusions.

When they analysed the data 15 months after the start of the trial, the researchers found that there was no evidence of any cancer remaining in the breast in 41.3% of women with HER2-positive tumours who had received both chemotherapy and trastuzumab; whereas the pathologic complete response rate (pCR, complete disappearance of cancer cells from the breast) was 19.5% in women who had not received trastuzumab.

Prof Untch said: Previous studies have shown that HER2-positive women who do not receive trastuzumab never have a pCR rate that exceeds 20%. Our study has shown that it is possible to combine trastuzumab with anthracycline/taxane chemotherapy regimen without any significant adverse effects on the heart, thereby significantly increasing the pCR rates for these women to 41.3%.

The researchers are continuing to follow the women to see whether the pCR rates translate into improved overall survival. In addition, they have started a further trial, the GeparQuinto study, which will compare the combination of chemotherapy plus trastuzumab with lapatinib (a tyrosine kinase inhibitor) as a pre-operative treatment.

The GeparQuattro trial was run jointly in more then 100 breast cancer centres by the German Breast Group (GBG) and the Arbeitsgemeinschaft Gynkologische Onkologie (AGO), the two major German cooperative research groups for the treatment of gynaecological malignancies and breast cancer. Professor Gunter von Minckwitz, managing director of GBG, is the principal investigator for the study.


'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2

Related biology news :

1. UC health news: molecular pathway may predict chemotherapy effectiveness
2. A search for protection against chemotherapy cardiotoxicity
3. Standard chemo works better against metastatic BRCA1/2 breast cancer than against sporadic tumors
4. New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients
5. Exercise improves thinking, reduces diabetes risk in overweight children
6. Endobronchial valve significantly improves emphysema
7. Teamwork improves learning and career success
8. New clinical data shows chromium picolinate improves cognitive function
9. Stem-cell transplantation improves muscles in MD animal model, UT Southwestern researchers report
10. Key to out-of-control immune response in lung injury found
11. Flies can turn off their immune response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... sense of fairness did not evolve for the sake ... the benefits of continued cooperation, so say Frans de ... review article about inequity aversion (IA), which is defined ... is published in Science . , Their ... IA-related studies to address their hypothesis that it is ...
(Date:9/18/2014)... University researchers have developed a unique method to use ... in rural areas. , The first microbe-powered, self-sustaining ... quick way to clean up waste from large farming ... , Professor Haluk Beyenal and graduate student Timothy ... discuss the system in the online edition of ...
(Date:9/18/2014)... New research into the Crimean-Congo hemorrhagic fever virus (CCHFV), ... in humans similar to that caused by Ebolavirus, has ... discovery has the potential to lead to novel targets ... The research, reported in a paper published today in ... scientists at the Texas Biomedical Research Institute and their ...
Breaking Biology News(10 mins):Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3Researchers develop unique waste cleanup for rural areas 2Research milestone in CCHF virus could help identify new treatments 2
... virus called cytomegalovirus (CMV), which most commonly affects people ... patients who have no immune-system problems, University of Washington ... longer hospital and intensive-care unit (ICU) stays independent of ... in JAMA , the Journal of the ...
... stem cells originate in a different part of the brain ... produce new brain cells to replace those lost to disease ... Evidence strongly shows that the true stem cells in ... ventricles in the brain and spinal cord, rather than cells ...
... In the life of a cell, the response to DNA damage ... commit suicide, or grow uncontrollably, a route leading to cancer. In ... Cell , scientists at NYU Langone Medical Center have identified a ... targets proteins for disposal. The finding points to a new pathway ...
Cached Biology News:CMV infections affect more than just patients with compromised immune systems, researchers find 2Adult stem cells activated in mammalian brain 2Adult stem cells activated in mammalian brain 3A new cellular pathway linked to cancer is identified by NYU researchers 2
(Date:9/18/2014)... BELLINGHAM, Washington, USA (PRWEB) September 18, 2014 ... of Representatives of a bill designed to stimulate development ... high-value jobs is being praised by leaders of ... The bill, the Revitalizing American Manufacturing and Innovation (RAMI) ... vote. The bill’s authors have said they are optimistic ...
(Date:9/18/2014)... -- DeepResearchReports.com adds "2014 Deep Research Report on ... Deep Research Report on Global and China Sodium ... Photo - http://photos.prnewswire.com/prnh/20140918/147058 ... China Acetic Acid Industry" is a professional and ... and Global Acetic Acid Market. The report ...
(Date:9/18/2014)... September 18, 2014 ... http://www.researchandmarkets.com/research/czvg3s/biocompatible ) has announced the addition ... Global Strategic Business Report" report ... ,This report analyzes the worldwide markets ... by the following Product Segments: Polymeric ...
(Date:9/18/2014)... DUBLIN , Sept. 18, 2014 ... the "Global and Chinese Stem Cell Industry Report, ... Stem cells are undifferentiated biological cells that can differentiate ... produce more stem cells. Stem cell therapy can be ... of hematological system disease), nervous system diseases, damage or ...
Breaking Biology Technology:House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 2Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 3Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 4Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3
... , , , ... NBIX ) announced today that the Company will report its second ... July 29, 2009. Neurocrine will then host a live conference ... update Thursday morning, July 30, 2009 at 8:30 a.m. Eastern Daylight Time ...
... , , , ... Group , , NEW ... non-invasive molecular oncology diagnostics to aid in early cancer detection ... named Chief Operating Officer. As COO, Zdechlik will be ...
... ... the keynote address , ... Parsipany, NJ (PRWEB) July 22, 2009 -- Vistaar Technologies, Inc. Vistaar ... announced the company will partner with the Professional Pricing Society (PPS), the world,s only ...
Cached Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2009 Financial Results 2Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer 2Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners 2Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners 3
... cassette is designed to allow ampicillin selection ... gb2 driving the gene for ampicillin resistance ... Em7 promoter. It mediates higher transcription efficiency ... synthetic polyadenylation signal terminates the ampicillin expression. ...
... PRO S-7 stirrers deliver accurate ... channels fluids away from internal ... easy-to-use controls which allow users ... ceramic tops feature a chemical ...
... Agencourt AMPure is a magnetic ... requires no sample transfer, centrifugation ... purifies small and large PCR ... 384-well microplates. Agencourt AMPure can ...
... These 1.5L PYREX trypsinizing ... homogenous tissue samples into cell ... proteins. Heavy beaded neck accepts ... enhance vigorous agitation. • Height ...
Biology Products: